{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:13:04Z","timestamp":1790799184869,"version":"4.1.0"},"reference-count":98,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Antimicrobial resistance is an urgent threat to public health and global development; in this scenario, the SARS-CoV2 pandemic has caused a major disruption of healthcare systems and practices. A narrative review was conducted on articles focusing on the impact of COVID-19 on multidrug-resistant gram-negative, gram-positive bacteria, and fungi. We found that, worldwide, multiple studies reported an unexpected high incidence of infections due to methicillin-resistant S. aureus, carbapenem-resistant A. baumannii, carbapenem-resistant Enterobacteriaceae, and C. auris among COVID-19 patients admitted to the intensive care unit. In this setting, inappropriate antimicrobial exposure, environmental contamination, and discontinuation of infection control measures may have driven selection and diffusion of drug-resistant pathogens.<\/jats:p>","DOI":"10.3390\/v13112110","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T22:07:04Z","timestamp":1634767624000},"page":"2110","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5276-2603","authenticated-orcid":false,"given":"Francesco Vladimiro","family":"Segala","sequence":"first","affiliation":[{"name":"Clinic of Infectious Diseases, Catholic University of the Sacred Heart, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4833-7118","authenticated-orcid":false,"given":"Davide Fiore","family":"Bavaro","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, University of Bari, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3453-5647","authenticated-orcid":false,"given":"Francesco","family":"Di Gennaro","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, University of Bari, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2273-0683","authenticated-orcid":false,"given":"Federica","family":"Salvati","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, Catholic University of the Sacred Heart, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4199-9060","authenticated-orcid":false,"given":"Claudia","family":"Marotta","sequence":"additional","affiliation":[{"name":"General Directorate of Health Prevention, Ministry of Health, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Saracino","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, University of Bari, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9468-5458","authenticated-orcid":false,"given":"Rita","family":"Murri","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, Catholic University of the Sacred Heart, 00168 Rome, Italy"},{"name":"Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Fantoni","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, Catholic University of the Sacred Heart, 00168 Rome, Italy"},{"name":"Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2021, August 11). 10 Global Health Issues to Track in 2021. Available online: https:\/\/www.who.int\/news-room\/spotlight\/10-global-health-issues-to-track-in-2021."},{"key":"ref_2","unstructured":"The World Bank (2021, August 16). Drug-Resistant Infections: A Threat to Our Economic Future. Available online: https:\/\/www.worldbank.org\/en\/topic\/health\/publication\/drug-resistant-infections-a-threat-to-our-economic-future."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1056\/NEJMra0904124","article-title":"Hospital-acquired infections due to gram-negative bacteria","volume":"362","author":"Peleg","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/cid\/cis552","article-title":"Costs of healthcare and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms","volume":"55","author":"Neidell","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/cid\/ciaa1581","article-title":"National estimates of healthcare costs associated with multidrug-resistant bacterial infections among hospitalized patients in the United States","volume":"72","author":"Nelson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","unstructured":"European Centre for Disease Prevention and Control (2021, August 12). Antimicrobial resistance in the EU\/EEA (EARS-Net)\u2014Annual Epidemiological Report for 2019. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2019."},{"key":"ref_7","unstructured":"Centers for Disease Control and Prevention (U.S.) (2019). Antibiotic Resistance Threats in the United States 2019, Centers for Disease Control and Prevention (U.S.)."},{"key":"ref_8","unstructured":"World Health Organization (2021, August 16). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report. Available online: https:\/\/www.who.int\/publications-detail-redirect\/9789240027336."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4269\/ajtmh.18-0394","article-title":"High burden of extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli and klebsiella pneumoniae bacteremia in older adults: A seven-year study in two rural Thai provinces","volume":"100","author":"Sawatwong","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_10","first-page":"46","article-title":"Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union\/European Economic Area, 2001 to 2018","volume":"24","author":"Weist","year":"2019","journal-title":"Eurosurveillance"},{"key":"ref_11","unstructured":"European Centre for Disease Prevention and Control (2021, August 16). Rapid risk Assessment: Carbapenem-Resistant Acinetobacter Baumannii in Healthcare Settings\u20148 December 2016. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/rapid-risk-assessment-carbapenem-resistant-acinetobacter-baumannii-healthcare."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJMra070741","article-title":"Acinetobacter infection","volume":"358","author":"Weinstein","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1086\/502205","article-title":"Acinetobacter outbreaks, 1977\u20132000","volume":"24","author":"Villegas","year":"2003","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/cid\/cir308","article-title":"comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008","volume":"53","author":"Talan","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"18033","DOI":"10.1038\/nrdp.2018.33","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"4","author":"Lee","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Li, Z., Zhuang, H., Wang, G., Wang, H., and Dong, Y. (2021). Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: Systemic review and meta-analysis. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-05763-y"},{"key":"ref_17","unstructured":"United Nations (2021, August 16). IAEG-SDGs\u2014SDG Indicators. Available online: https:\/\/unstats.un.org\/sdgs\/iaeg-sdgs\/2020-comprev\/UNSC-proposal."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1038\/s41598-020-62371-7","article-title":"Genomic Epidemiology of vancomycin-resistant enterococcus faecium (VREfm) in Latin America: Revisiting the global VRE population structure","volume":"10","author":"Rios","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/14787210.2020.1750368","article-title":"Multidrug-resistant Candida auris: An epidemiological review","volume":"18","author":"Chakrabarti","year":"2020","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2147\/IDR.S249864","article-title":"Candida auris: From multidrug resistance to pan-resistant strains","volume":"13","author":"Ademe","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e00029-17","DOI":"10.1128\/CMR.00029-17","article-title":"Candida auris: A review of the literature","volume":"31","author":"Taori","year":"2018","journal-title":"Clin Microbiol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: Rapid review and meta-analysis","volume":"27","author":"Langford","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis","volume":"26","author":"Langford","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3201\/eid1408.070751","article-title":"Bacterial pneumonia and pandemic influenza planning","volume":"14","author":"Gupta","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Musuuza, J.S., Watson, L., Parmasad, V., Putman-Buehler, N., Christensen, L., and Safdar, N. (2021). Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0251170"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s15010-020-01553-x","article-title":"Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia","volume":"49","author":"Elabbadi","year":"2021","journal-title":"Infection"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Punjabi, C.D., Madaline, T., Gendlina, I., Chen, V., Nori, P., and Pirofski, L.-A. (2020). Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in respiratory cultures and diagnostic performance of the MRSA nasal polymerase chain reaction (PCR) in patients hospitalized with coronavirus disease 2019 (COVID-19) pneumonia. Infect. Control Hosp. Epidemiol., 1\u20132.","DOI":"10.1017\/ice.2020.440"},{"key":"ref_28","first-page":"Doc29","article-title":"Random effects meta-analysis of COVID-19\/S. aureus partnership in co-infection","volume":"15","author":"Adeiza","year":"2020","journal-title":"GMS Hyg. Infect. Control"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13054-021-03623-4","article-title":"Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: Clinical features and potential inference with lung dysbiosis","volume":"25","author":"Carelli","year":"2021","journal-title":"Crit. Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e995","DOI":"10.1093\/cid\/ciaa1748","article-title":"Risk factors and outcomes of hospitalized patients with severe Coronavirus disease 2019 (COVID-19) and secondary bloodstream infections: A multicenter case-control study","volume":"72","author":"Bhatt","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"ofaa518","DOI":"10.1093\/ofid\/ofaa518","article-title":"Staphylococcus aureus bacteremia in patients infected with COVID-19: A case series","volume":"7","author":"Cusumano","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Calder\u00f3n-Parra, J., Mui\u00f1o-Miguez, A., Bendala-Estrada, A.D., Ramos-Mart\u00ednez, A., Mu\u00f1ez-Rubio, E., Carracedo, E.F., Montes, J.T., Rubio-Rivas, M., Arnalich-Fernandez, F., and P\u00e9rez, J.L.B. (2021). Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0251340"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.3389\/fmicb.2020.590683","article-title":"Antimicrobial Resistance as a hidden menace lurking behind the COVID-19 outbreak: The global impacts of too much hygiene on AMR","volume":"11","author":"Rezasoltani","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2710.2006.00701.x","article-title":"The influence of antibiotic use on the occurrence of vancomycin-resistant enterococci","volume":"31","author":"Kolar","year":"2006","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"eaat8418","DOI":"10.1126\/scitranslmed.aat8418","article-title":"Impact of antibiotic treatment and host innate immune pressure on enterococcal adaptation in the human bloodstream","volume":"11","author":"Manson","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"572912","DOI":"10.3389\/fcimb.2020.572912","article-title":"Antibiotics as major disruptors of gut microbiota","volume":"10","author":"Ramirez","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.eng.2020.05.013","article-title":"Clinical significance of the correlation between changes in the major intestinal bacteria species and COVID-19 severity","volume":"6","author":"Tang","year":"2020","journal-title":"Engineering"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13756-020-00820-8","article-title":"A nosocomial cluster of vancomycin resistant enterococci among COVID-19 patients in an intensive care unit","volume":"9","author":"Kampmeier","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/CCM.0000000000004748","article-title":"Unexpectedly high frequency of enterococcal bloodstream infections in Coronavirus disease 2019 patients admitted to an Italian ICU: An observational study","volume":"49","author":"Bonazzetti","year":"2021","journal-title":"Crit. Care Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10096-020-04142-w","article-title":"Nosocomial infections associated to COVID-19 in the intensive care unit: Clinical characteristics and outcome","volume":"40","author":"Bardi","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1017\/ice.2020.1360","article-title":"Change in hospital antibiotic use and acquisition of multidrug-resistant gram-negative organisms after the onset of coronavirus disease","volume":"42","author":"Bork","year":"2021","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Dumitru, I., Dumitrascu, M., Vlad, N., Cernat, R., Ilie-Serban, C., Hangan, A., Slujitoru, R., Gherghina, A., Mitroi-Maxim, C., and Curtali, L. (2021). Carbapenem-resistant Klebsiella pneumoniae associated with COVID-19. Antibiotics, 10.","DOI":"10.3390\/antibiotics10050561"},{"key":"ref_43","first-page":"100113","article-title":"An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital","volume":"3","author":"Gottesman","year":"2021","journal-title":"Infect. Prev. Pr."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Magnasco, L., Mikulska, M., Giacobbe, D., Taramasso, L., Vena, A., Dentone, C., Dettori, S., Tutino, S., Labate, L., and Di Pilato, V. (2021). Spread of carbapenem-resistant gram-negatives and Candida auris DuriNG The COVID-19 pandemic in critically Ill patients: One step back in antimicrobial stewardship?. Microorganisms, 9.","DOI":"10.3390\/microorganisms9010095"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"M\u0119drzycka-D\u0105browska, W., Lange, S., Zorena, K., D\u0105browski, S., Ozga, D., and Tomaszek, L. (2021). Carbapenem-Resistant Klebsiella pneumoniae infections in ICU COVID-19 patients\u2014A scoping review. J. Clin. Med., 10.","DOI":"10.3390\/jcm10102067"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Arteaga-Livias, K., Pinzas-Acosta, K., Perez-Abad, L., Panduro-Correa, V., Rabaan, A.A., Pecho-Silva, S., and D\u00e1maso-Mata, B. (2021). A multidrug-resistant Klebsiella pneumoniae outbreak in a Peruvian hospital: Another threat from the COVID-19 pandemic. Infect. Control Hosp. Epidemiol., 1\u20132.","DOI":"10.1017\/ice.2020.1401"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/mdr.2020.0489","article-title":"Multidrug-resistant infections and outcome of critically Ill patients with Coronavirus disease 2019: A single center experience","volume":"27","author":"Karruli","year":"2021","journal-title":"Microb. Drug Resist."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/jac\/dkz125","article-title":"Reversal of carbapenemase-producing Klebsiella pneumoniae epidemiology from blaKPC- to blaVIM-harbouring isolates in a Greek ICU after introduction of ceftazidime\/avibactam","volume":"74","author":"Bartzavali","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"106179","DOI":"10.1016\/j.ijantimicag.2020.106179","article-title":"Emerging co-pathogens: New Delhi metallo-beta-lactamase producing enterobacterales infections in New York City COVID-19 patients","volume":"56","author":"Nori","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2147\/IDR.S257477","article-title":"Emergence of hypervirulent ceftazidime\/avibactam-resistant Klebsiella pneumoniae isolates in a Chinese tertiary hospital","volume":"13","author":"Li","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex Immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Netea","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Russo, A., Gavaruzzi, F., Ceccarelli, G., Borrazzo, C., Oliva, A., Alessandri, F., Magnanimi, E., Pugliese, F., and Venditti, M. (2021). Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection, 1\u201310.","DOI":"10.1007\/s15010-021-01643-4"},{"key":"ref_54","unstructured":"Nebreda-Mayoral, T., Miguel-G\u00f3mez, M.A., March-Rossell\u00f3, G.A., Puente-Fuertes, L., Cant\u00f3n-Benito, E., Mart\u00ednez-Garc\u00eda, A.M., Mu\u00f1oz-Mart\u00edn, A.B., and Ordu\u00f1a-Domingo, A. (2020). Bacterial\/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the Community of Castilla y Le\u00f3n, Spain. Enferm. Infecc. Microbiol. Cl\u00ednica, in press."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Shinohara, D.R., Saalfeld, S.M.D.S., Martinez, H.V., Altafini, D.D., Costa, B.B., Fedrigo, N.H., and Tognim, M.C.B. (2021). Outbreak of endemic carbapenem-resistant Acinetobacter baumannii in a coronavirus disease 2019 (COVID-19)\u2014Specific intensive care unit. Infect. Control Hosp. Epidemiol., 1\u20133.","DOI":"10.1017\/ice.2021.98"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Sharifipour, E., Shams, S., Esmkhani, M., Khodadadi, J., Fotouhi-Ardakani, R., Koohpaei, A., Doosti, Z., and Golzari, S.E. (2020). Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05374-z"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3855\/jidc.13545","article-title":"Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19","volume":"15","year":"2021","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Pascale, R., Bussini, L., Gaibani, P., Bovo, F., Fornaro, G., Lombardo, D., Ambretti, S., Pensalfine, G., Appolloni, L., and Bartoletti, M. (2021). Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study. Infect. Control Hosp. Epidemiol., 1\u20136.","DOI":"10.1017\/ice.2021.144"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/14740338.2020.1767585","article-title":"Targeted therapies for autoimmune\/idiopathic nonmalignant diseases: Risk and management of opportunistic infections","volume":"19","author":"Bavaro","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1093\/cid\/ciaa954","article-title":"Tocilizumab for treatment of mechanically ventilated patients with COVID-19","volume":"73","author":"Somers","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/cid\/ciaa1410","article-title":"Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant gram-negative infections in intensive care unit patients","volume":"72","author":"Falcone","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Bavaro, D., Belati, A., Diella, L., Stufano, M., Romanelli, F., Scalone, L., Stolfa, S., Ronga, L., Maurmo, L., and Dell\u2019Aera, M. (2021). Cefiderocol-based combination therapy for \u201cdifficult-to-treat\u201d gram-negative severe infections: Real-life case series and future perspectives. Antibiotics, 10.","DOI":"10.3390\/antibiotics10060652"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"104806","DOI":"10.1016\/j.micinf.2021.104806","article-title":"Bacterial and fungal co-infections among COVID-19 patients in intensive care unit","volume":"23","author":"Yang","year":"2021","journal-title":"Microbes Infect."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s13054-019-2649-5","article-title":"Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: A nationwide retrospective study","volume":"23","author":"Guerci","year":"2019","journal-title":"Crit. Care"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1871526521666210203220718","article-title":"Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a patient with Hodgkin\u2019s lymphoma history from north of Iran","volume":"21","author":"Darvishnia","year":"2021","journal-title":"Infect. Disord. Drug Targets"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e242670","DOI":"10.1136\/bcr-2021-242670","article-title":"Treatment refractory Stenotrophomonas maltophilia bacteraemia and pneumonia in a COVID-19-positive patient","volume":"14","author":"Pek","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2147\/IDR.S299774","article-title":"Secondary infections in hospitalized COVID-19 patients: Indian experience","volume":"14","author":"Vijay","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"641920","DOI":"10.3389\/fcimb.2021.641920","article-title":"Persistent bacterial coinfection of a COVID-19 patient caused by a genetically adapted Pseudomonas aeruginosa chronic colonizer","volume":"11","author":"Qu","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2165\/00003495-200868140-00002","article-title":"Patients at high risk of invasive fungal infections: When and how to treat","volume":"68","author":"Vehreschild","year":"2008","journal-title":"Drugs"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S2213-2600(21)00265-4","article-title":"Rising incidence of mucormycosis in patients with COVID-19: Another challenge for India amidst the second wave?","volume":"9","author":"Raut","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","article-title":"A national strategy to diagnose Coronavirus disease 2019\u2014Associated Invasive fungal disease in the intensive care unit","volume":"73","author":"White","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e02136-20","DOI":"10.1128\/JCM.02136-20","article-title":"COVID-19-Associated invasive Aspergillosis: Data from the UK national mycology reference laboratory","volume":"59","author":"Borman","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.202005-2018LE","article-title":"Detection of Invasive Pulmonary Aspergillosis in COVID-19 with Non-directed Bronchoalveolar Lavage","volume":"202","author":"Kwa","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13613-020-00686-4","article-title":"COVID-19-associated invasive pulmonary aspergillosis","volume":"10","author":"Rutsaert","year":"2020","journal-title":"Ann. Intensive Care"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19","volume":"8","author":"Alanio","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: The 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Meijer, E.F.J., Dofferhoff, A.S.M., Hoiting, O., Buil, J.B., and Meis, J.F. (2020). Azole-resistant COVID-19-associated pulmonary aspergillosis in an immunocompetent host: A case report. J. Fungi, 6.","DOI":"10.3390\/jof6020079"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mmcr.2020.06.005","article-title":"Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination","volume":"31","author":"Mohamed","year":"2020","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/QCO.0000000000000662","article-title":"Aspergillus fumigatus and pan-azole resistance: Who should be concerned?","volume":"33","author":"Wiederhold","year":"2020","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_80","first-page":"15","article-title":"Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU\u2014A case report","volume":"31","author":"Saade","year":"2020","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Arastehfar, A., Shaban, T., Zarrinfar, H., Roudbary, M., Ghazanfari, M., Hedayati, M.-T., Sedaghat, A., Ilkit, M., Najafzadeh, M., and Perlin, D. (2021). Candidemia among Iranian patients with severe COVID-19 admitted to ICUs. J. Fungi, 7.","DOI":"10.3390\/jof7040280"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Arastehfar, A., Carvalho, A., Nguyen, M.H., Hedayati, M.T., Netea, M.G., Perlin, D.S., and Hoenigl, M. (2020). COVID-19-associated candidiasis (CAC): An underestimated complication in the absence of immunological predispositions?. J. Fungi, 6.","DOI":"10.3390\/jof6040211"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Di Pilato, V., Codda, G., Ball, L., Giacobbe, D., Willison, E., Mikulska, M., Magnasco, L., Crea, F., Vena, A., and Pelosi, P. (2021). Molecular epidemiological investigation of a nosocomial cluster of C. auris: Evidence of recent emergence in Italy and ease of transmission during the COVID-19 pandemic. J. Fungi, 7.","DOI":"10.3390\/jof7020140"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"6","DOI":"10.15585\/mmwr.mm6901a2","article-title":"Candida auris isolates resistant to three classes of antifungal medications\u2014New York, 2019","volume":"69","author":"Ostrowsky","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/myc.13320","article-title":"Axillary digital thermometers uplifted a multidrug-susceptible Candida auris outbreak among COVID-19 patients in Brazil","volume":"64","author":"Francisco","year":"2021","journal-title":"Mycoses"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.3201\/eid2611.203504","article-title":"Multidrug-resistant Candida auris infections in critically Ill Coronavirus disease patients, India, April\u2013July 2020","volume":"26","author":"Chowdhary","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cmi.2020.12.030","article-title":"Outbreak of Candida auris infection in a COVID-19 hospital in Mexico","volume":"27","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Toro-Alzate, L., Hofstraat, K., and de Vries, D.H. (2021). The pandemic beyond the pandemic: A Scoping review on the social relationships between COVID-19 and antimicrobial resistance. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18168766"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S2213-2600(20)30161-2","article-title":"Intensive care management of coronavirus disease 2019 (COVID-19): Challenges and recommendations","volume":"8","author":"Phua","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmi.2020.09.041","article-title":"Recommendations for antibacterial therapy in adults with COVID-19\u2014An evidence based guideline","volume":"27","author":"Sieswerda","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","article-title":"Surviving sepsis campaign: Guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)","volume":"46","author":"Alhazzani","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"572","DOI":"10.7196\/SAMJ.2020.v110i7.14917","article-title":"Collateral damage of the Covid-19 Pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes?","volume":"110","author":"Chibabhai","year":"2020","journal-title":"S. Afr. Med. J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/cid\/ciaa212","article-title":"De-escalation of Empiric antibiotics following negative cultures in hospitalized patients with pneumonia: Rates and outcomes","volume":"72","author":"Deshpande","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.3201\/eid2609.202126","article-title":"Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March\u2013April 2020","volume":"26","author":"Sandhu","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Granata, G., Bartoloni, A., Codeluppi, M., Contadini, I., Cristini, F., Fantoni, M., Ferraresi, A., Fornabaio, C., Grasselli, S., and Lagi, F. (2020). The burden of clostridioides difficile infection during the COVID-19 pandemic: A retrospective case-control study in Italian hospitals (CloVid). J. Clin. Med., 9.","DOI":"10.3390\/jcm9123855"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3201\/eid2704.204036","article-title":"Rapid spread and control of multidrug-resistant gram-negative bacteria in COVID-19 patient care units","volume":"27","author":"Patel","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11908-018-0620-2","article-title":"The Role of environmental contamination in the transmission of nosocomial pathogens and healthcare-associated infections","volume":"20","author":"Suleyman","year":"2018","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.15585\/mmwr.mm6948e1","article-title":"Increase in hospital-acquired carbapenem-resistant Acinetobacter baumannii infection and colonization in an acute care hospital During a surge in COVID-19 admissions\u2014New Jersey, February\u2013July 2020","volume":"69","author":"Perez","year":"2020","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/11\/2110\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:18:58Z","timestamp":1760167138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/11\/2110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":98,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["v13112110"],"URL":"https:\/\/doi.org\/10.3390\/v13112110","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]}}}